181 related articles for article (PubMed ID: 9490667)
21. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism.
Meads MB; Medveczky PG
J Biol Chem; 2004 Dec; 279(50):51793-803. PubMed ID: 15258150
[TBL] [Abstract][Full Text] [Related]
22. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
Kovacs E
Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
[TBL] [Abstract][Full Text] [Related]
23. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
Giffin L; West JA; Damania B
mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
[TBL] [Abstract][Full Text] [Related]
26. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
27. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA), and GP130 antagonist (GP130A) using various parameters in an in vitro model.
Kovacs E
ScientificWorldJournal; 2006 Aug; 6():888-98. PubMed ID: 16892169
[TBL] [Abstract][Full Text] [Related]
28. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.
Hu F; Nicholas J
J Virol; 2006 Nov; 80(21):10874-8. PubMed ID: 16956953
[TBL] [Abstract][Full Text] [Related]
30. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.
Foussat A; Wijdenes J; Bouchet L; Gaidano G; Neipel F; Balabanian K; Galanaud P; Couderc J; Emilie D
Eur Cytokine Netw; 1999 Dec; 10(4):501-8. PubMed ID: 10586116
[TBL] [Abstract][Full Text] [Related]
31. Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.
Adam N; Rabe B; Suthaus J; Grötzinger J; Rose-John S; Scheller J
J Virol; 2009 May; 83(10):5117-26. PubMed ID: 19264784
[TBL] [Abstract][Full Text] [Related]
32. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
[TBL] [Abstract][Full Text] [Related]
33. Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.
Cousins E; Nicholas J
J Virol; 2013 Oct; 87(19):10816-27. PubMed ID: 23903842
[TBL] [Abstract][Full Text] [Related]
34. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
35. Human Herpesvirus 8 Interleukin-6 Interacts with Calnexin Cycle Components and Promotes Protein Folding.
Chen D; Xiang Q; Nicholas J
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878084
[TBL] [Abstract][Full Text] [Related]
36. Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6.
Chen D; Sandford G; Nicholas J
J Virol; 2009 Jan; 83(2):722-33. PubMed ID: 18987143
[TBL] [Abstract][Full Text] [Related]
37. STAT3 is constitutively activated in Hodgkin cell lines.
Kube D; Holtick U; Vockerodt M; Ahmadi T; Haier B; Behrmann I; Heinrich PC; Diehl V; Tesch H
Blood; 2001 Aug; 98(3):762-70. PubMed ID: 11468177
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
Brocke-Heidrich K; Kretzschmar AK; Pfeifer G; Henze C; Löffler D; Koczan D; Thiesen HJ; Burger R; Gramatzki M; Horn F
Blood; 2004 Jan; 103(1):242-51. PubMed ID: 12969979
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion.
Mori Y; Nishimoto N; Ohno M; Inagi R; Dhepakson P; Amou K; Yoshizaki K; Yamanishi K
J Med Virol; 2000 Jul; 61(3):332-5. PubMed ID: 10861641
[TBL] [Abstract][Full Text] [Related]
40. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
